@AMPELBio

Precision med company bringing decision support blood and skin biopsy tests to doctors/patients to determine disease status, molecular pathway & drug options.

 Charlottesville, VA
ampelbiosolutions.com
Joined July 2019
  • Tweets24
  • Following13
  • Followers68
4Media
@AMPELBio collaborating w/ @wakeforestmed published breakthrough study in @CellRepMed fueling a #precisionmedicine #CardioGENE blood test to predict #genetic susceptibility to #cardiovascular events even w/o traditional risk factors of smoking, high fat diet & sedentary lifestyle
1
1
Link to breakthrough study demonstrating blood test to predict susceptibility to cardiovascular events published today in @CellRepMed cell.com/cell-reports-medici…

Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus...

Kain et al. report a positive genetic relationship between SLE and CAD using traditional and comprehensive Mendelian randomization (MR) approaches. MR analysis coupled with network modeling highlig...

cell.com
1
1
Press Release on breakthrough study with @wakeforestmed prnewswire.com/news-releases…

EARLY GENETIC TESTING PREDICTS HEART DISEASE AND NOVEL THERAPIES FOR WOMEN WITH LUPUS

/PRNewswire/ -- AMPEL BioSolutions today announced a genetic precision medicine test for lupus patients that could save lives by predicting heart disease...

prnewswire.com
AMPEL BioSolutions’ new genomics CovGENE product proves to have 90%+ accuracy in predicting severity of COVID-19 in positive patients. prn.to/3dfSfFX @AmrieAMPEL #COVID19 #SARS-Cov2 #personalizedmedicine #GeneExpression

NEW BREAKTHROUGH TEST DETECTS AND PREDICTS SEVERITY OF COVID-19

/PRNewswire/ -- AMPEL BioSolutions today announced a breakthrough in precision and personalized medicine that can detect and predict the severity of COVID-19...

prnewswire.com
1
We're excited to announce a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer prn.to/3OLpm1R
2
AMPEL BioSolutions retweeted
NatRevRheumatol@NatRevRheumatol2 Nov 2021
Online now! An introduction to machine learning and analysis of its use in rheumatic diseases #RheumTwitter #rheumatology #MachineLearning #MedEd go.nature.com/3q3gL0T
21
1
36
Dr. Grammer to introduce one of AMPEL’s products expected to commercialize in 2022. LuGENE®, a CLIA-certified blood test for patients/physicians, assesses disease state/flares and best drug options for lupus patients. prn.to/3AgdKg0
Thank you @vabio @Va_DrugDisc for the opportunity to speak today on the prediction of COVID 19 disease severity and best drug options for patients at the symposium on "Coronavirus: Present and Future
1
Informative webinar on June 23 featuring AMPEL's own @AmrieAMPEL! Click here to register: eventbrite.com/e/a-conversat…
Tonight @NBC29 at 5 & 6 will air a discussion on @AMPELBio technology that identifies medicines to blunt lung damage experienced by severe #Covid_19 patients with AMPEL CSO @AmrieAMPEL Tune in Tonight! @BioHealthCR @VanHipp @katevega20
1
2
AMPEL is looking for licensing partners to bring it's Covid19 prognostic to market and for scientists with validation datasets to collaborate! #Covid19 @AmrieAMPEL @VanHipp @katevega20 wina.com/podcasts/charl
Van Hipp
@VanHipp11 Jun 2020
Gene-based test predicts severity of illness in #COVID19 patients & identifies best FDA approved treatments! @AMPELBio shows what American Small Biz can do! biohealthinnovation.anyimage…
CovGENE: AMPEL’s Novel Prognostic Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments. learn more ampelbiosolutions.com/covgen… #COVIDResearch #covgene prn.to/3f1WKPq
@AMPELBio announces the kickoff of a Series A $12.5M raise to commercialize LuGENETM, a gene-based diagnostic at the Biotech Showcase at JP Morgan Healthcare #personalizedmedicine #precisionmedicine #permedcoalition #lupus #SLE prn.to/36ZhQul
1
1
AMPEL BioSolutions is at the VCU career fair today, booth 50. Stop by and learn more about our opportunities. @VCU @VCAENGR @VCU_CCTR #MachineLearning #BioInformatics #internships #AI #researcher #immunology #lupus #autoimmunedisease
1
1
Nice write up on AMPEL's work on interferons in Lupus, led by Senior Scientist Michelle Catalina. #ai #lupus #machinelearning the-rheumatologist.org/artic…

Multiple Interferons, Including IFNB1, May Play a Role in SLE - The Rheumatologist

A recent gene expression analysis found an enriched downstream interferon signature, with predominantly IFNB1 signatures in systemic lupus erythematosus (SLE) patients. The study also found lower...

the-rheumatologist.org
Dr. Amrie Grammer of AMPEL BioSolutions joins host Rich Bendis on BioTalk dlvr.it/R81z6x
1
1
Dr. @AmrieGrammer of AMPEL BioSolutions joins Rich on a new episode of BioTalk. Listen now on iTunes (apple.co/2LGI6Sp), Google Play (bit.ly/2JnfxI9), and TuneIn (bit.ly/2JnfxI9).
3
6
New insights achieved by the combination of bioinformatics and genomics data through machine learning could help the way doctors treat chronic diseases like lupus, according to a paper published in the journal Nature Scientific Reports publichealth.gwu.edu/content…
2
1
@AMPELBioSoluti1 announces breakthrough in precision & personalized medicine could revolutionize the way doctors treat chronic diseases like Lupus. In Nature’s Scientific Reports, paper details machine learning approach to predict disease activity. rdcu.be/bIrse #Lupus
RILITE Foundation is hosting a celebrity charity soccer event Kick Out Lupus. Event supports lupus research and awareness details and tickets: rilite.org/kick-out-lupus #lupus
1
1
Load more